Du är här

2014-05-01

Novavax, Inc.: Novavax to Report First Quarter Financial Results on May 7, 2014

GAITHERSBURG, Md., May 1, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX)
announced today that it will report its first quarter 2014 financial results
on Wednesday, May 7, 2014 after the close of the U.S. financial markets.

Following the earnings release, company management will host a conference call
and webcast to provide a corporate update and discuss its first quarter 2014
financial results. Details to access the conference call are as follows:

-------------------------------------------------------------------------------
|Date: Wednesday, May 7, 2014 |
|Time: 4:30 p.m. ET. |
|Call-in numbers: (877) 212-6076 (domestic) or (707) 287-9331 (international) |
|Webcast: www.novavax.com, via "Investor Info / Events" tab |
-------------------------------------------------------------------------------
A replay of the conference call will be available from 7:30 pm on May 7, 2014
until midnight June 7, 2014. To access the replay by telephone, dial 1 (855)
859-2056 (domestic) or 1 (404) 537-3406 (international) and use passcode
34845350. The replay will also be available as a webcast and can be found on
the "Investor Info / Events" tab on the Novavax website.

About Novavax

Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage biopharmaceutical company
creating novel vaccines and vaccine adjuvants to address a broad range of
infectious diseases worldwide. Using innovative proprietary recombinant
protein nanoparticle vaccine technology, the company produces vaccine
candidates to efficiently and effectively respond to both known and newly
emergent diseases. Additional information about Novavax is available on the
company's website, novavax.com.

CONTACT: Barclay Phillips
SVP, Chief Financial Officer and Treasurer
Novavax, Inc.
240-268-2000

---------------------------------------

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Novavax, Inc. via Globenewswire

HUG#1782140

Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.